US Patent 11020376 Crystalline form of lorlatinib free base
Patent 11020376 was granted and assigned to Pfizer Limited on June, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11020376 Crystalline form of lorlatinib free base
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
